040sek
4,8 %
Date:2025-05-13Time:18:00:00Latest report:Q4-2024List:Small CapTicker:IMMNOV
Market Cap:124 msekEnterprise Value:99 msekNet Sales:0,93 msekEarnings:−76,5 msekEmployees:0ISIN:SE0006091997

Ratios

10-year key figure history for Immunovia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Immunovia with index and moving average MA50 and MA200.

Stockprice:0,40
MA50:0,32
MA200:0,65
Price/MA200:-37,3 %
RSI (14):70,9
Price/MA50:28,2 %

Description

Immunovia operates in the biotechnology industry and focuses on the development of diagnostic tools for the early detection of cancer. The company's research and development is focused on molecular diagnostics and its products are aimed at healthcare institutions and physicians. The business is global with a strong presence in Europe and North America. Immunovia was founded in 2007 and is headquartered in Lund.

Medical Equipment